Pulmonary Idiopathic Arterial Hypertension Clinical Trial
Official title:
The Determination of Endothelial Progenitor Cells in Pulmonary Idiopathic Arterial Hypertension.
Endothelial dysfunction ultimately represents an imbalance between the magnitude of injury
and the capacity for repair.
Current evidence established that endothelial progenitor cells (EPC) participate in several
models of vascular disease as acute coronary syndromes, stroke, diabetes, peripheral artery
disease, etc. However EPC in the setting of PAH is less well established. The target of this
study is to demonstrate if the number of EPC is increased in a mexican population of patients
with PAH.
n/a